SPB Git

spb/wp45_uqo

Public
9.0 KB · 309 lines json
1{2 "validation_errors": [],3 "doc_id": "jof_12947",4 "ontology_version": "1.0",5 "prompt_version": "1.0",6 "model": "claude-opus-5-5",7 "effort": "medium",8 "annotated_at": "2026-11-03T23:15:26+00:00",9 "source_sha256": "d1da1153235f95ca279e99bd28e8bfcd9843e15d7edf32e7cdd9a0894aba4a85",10 "parser": "pymupdf-jof-heuristics-1.3",11 "payload_chars": 24710,12 "usage": {13  "input": 8908,14  "output": 2602,15  "cache_read": 3968,16  "cache_write": 017 },18 "cost_usd": 0.088466,19 "request_id": "req_011CggqxfhmwhyZrar8D4Yv4",20 "annotation": {21  "genre": "empirical",22  "subfield": "asset_pricing",23  "subfield_secondary": "behavioral_finance",24  "primary_method": "difference_in_differences",25  "identification": {26   "estimand": "Effect of relaxing short-sale constraints on monthly long-short anomaly portfolio returns (and on the long and short legs separately) for pilot versus nonpilot stocks during the pilot period",27   "strategy": "Natural experiment from the Regulation SHO pilot program, which suspended price tests for a quasi-randomly chosen set of stocks. Difference-in-differences regressions of portfolio returns use time fixed effects and a Pilot×During interaction, with a Pilot×Post term for the postpilot period.",28   "key_assumptions": [29    "Assignment of pilot stocks is quasi-random",30    "The regulatory shift alters only permitted short-selling and is uncorrelated with shifts in factor risk",31    "Absent the program, pilot and nonpilot anomaly returns would have evolved in parallel"32   ],33   "threats_addressed": [34    "Proxies for limits to arbitrage correlated with risk",35    "Balance of anomaly variables between pilot and nonpilot firms",36    "Spurious timing (placebo test with a fictitious pilot period)",37    "Risk adjustment with CAPM and Fama-French factors",38    "Low power from a short pilot period",39    "Sensitivity to sample period, exchange, and portfolio weighting"40   ],41   "causal_language_strength": 4,42   "uses_causal_claim": true43  },44  "abstract_moves": {45   "question": {46    "present": true,47    "sentence_index": 048   },49   "gap": {50    "present": false,51    "sentence_index": -152   },53   "method": {54    "present": true,55    "sentence_index": 056   },57   "results": {58    "present": true,59    "sentence_index": 160   },61   "magnitude": {62    "present": true,63    "sentence_index": 264   },65   "contribution": {66    "present": false,67    "sentence_index": -168   }69  },70  "introduction": {71   "moves": [72    {73     "paragraph_index": 0,74     "move": "motivation"75    },76    {77     "paragraph_index": 0,78     "move": "tension_or_puzzle"79    },80    {81     "paragraph_index": 1,82     "move": "literature_gap"83    },84    {85     "paragraph_index": 1,86     "move": "preview_of_approach"87    },88    {89     "paragraph_index": 2,90     "move": "mechanism_or_theory_sketch"91    },92    {93     "paragraph_index": 3,94     "move": "preview_of_approach"95    },96    {97     "paragraph_index": 3,98     "move": "preview_of_results"99    },100    {101     "paragraph_index": 4,102     "move": "preview_of_results"103    },104    {105     "paragraph_index": 5,106     "move": "preview_of_results"107    },108    {109     "paragraph_index": 5,110     "move": "robustness_mention"111    },112    {113     "paragraph_index": 6,114     "move": "related_literature_positioning"115    },116    {117     "paragraph_index": 7,118     "move": "literature_gap"119    },120    {121     "paragraph_index": 8,122     "move": "related_literature_positioning"123    },124    {125     "paragraph_index": 9,126     "move": "related_literature_positioning"127    },128    {129     "paragraph_index": 9,130     "move": "contribution_statement"131    },132    {133     "paragraph_index": 9,134     "move": "identification_defense"135    }136   ],137   "contribution_paragraph_index": 9,138   "contribution_types": [139    "new_evidence",140    "new_identification"141   ],142   "roadmap_present": false,143   "literature_positioning_location": "inside_introduction"144  },145  "section_roles": [146   {147    "idx": 0,148    "role": "introduction"149   },150   {151    "idx": 1,152    "role": "other"153   },154   {155    "idx": 2,156    "role": "data"157   },158   {159    "idx": 3,160    "role": "results"161   },162   {163    "idx": 4,164    "role": "robustness"165   },166   {167    "idx": 5,168    "role": "conclusion"169   },170   {171    "idx": 6,172    "role": "appendix"173   },174   {175    "idx": 7,176    "role": "appendix"177   },178   {179    "idx": 8,180    "role": "appendix"181   },182   {183    "idx": 9,184    "role": "appendix"185   }186  ],187  "results_presentation": {188   "economic_significance_discussed": true,189   "statistical_significance_language": "unclear",190   "magnitude_statements_in_intro": true191  },192  "robustness": {193   "location": "main_text_section",194   "types": [195    "alternative_sample_period",196    "placebo",197    "falsification",198    "subsample",199    "alternative_measure",200    "alternative_specification"201   ]202  },203  "tables": {204   "convention_notes": "Table notes write out the difference-in-differences regression equation, define the variables, and state the sample (NYSE/Amex pilot and nonpilot stocks) and the sample period. Coefficients are reported for each of the 11 anomalies and in aggregate. Return units are stated as monthly raw returns and alphas.",205   "units_stated_in_notes": true,206   "standard_errors_description": "unclear"207  },208  "figures": {209   "uncertainty_shown": "unclear"210  },211  "conclusion": {212   "bounded_claims": true,213   "policy_implications": false,214   "open_questions": false,215   "restates_contribution": true216  },217  "hedging": {218   "level": "moderate",219   "typical_devices": [220    "'suggests' when interpreting results as evidence of mispricing",221    "'consistent with' the hypotheses",222    "'quasi-random' qualifier on the assignment",223    "'unlikely to be correlated' with factor risk"224   ]225  },226  "claim_evidence": [227   {228    "claim": "Anomalies weakened for pilot-stock portfolios during the pilot; combined long-short returns fell by about 72 bp per month",229    "evidence_type": "table",230    "evidence_ref": "Table IV"231   },232   {233    "claim": "The effect comes from the short legs; long legs show no significant change",234    "evidence_type": "table",235    "evidence_ref": "Table IV"236   },237   {238    "claim": "The pilot-nonpilot difference vanished after the pilot program ended",239    "evidence_type": "table",240    "evidence_ref": "Table V"241   },242   {243    "claim": "Pilot short legs underperformed at the start of the pilot and outperformed at its end, relative to nonpilot short legs",244    "evidence_type": "figure",245    "evidence_ref": "Figure 1"246   },247   {248    "claim": "A fictitious 2001-2003 pilot period had no effect on the anomalies",249    "evidence_type": "table",250    "evidence_ref": "Table VII"251   },252   {253    "claim": "Pilot and nonpilot firms were similar in their anomaly variables before the program",254    "evidence_type": "table",255    "evidence_ref": "Table III"256   },257   {258    "claim": "Shorting activity differed between pilot and nonpilot short-leg portfolios over the program",259    "evidence_type": "figure",260    "evidence_ref": "Figure 2"261   },262   {263    "claim": "Results survive adjustment with CAPM and Fama-French three-factor benchmarks",264    "evidence_type": "table",265    "evidence_ref": "Appendix B"266   }267  ],268  "structural_summary": "The introduction frames the risk-versus-mispricing debate over anomalies and argues that existing limits-to-arbitrage proxies may capture risk. It proposes the Reg SHO pilot as a natural experiment and states two main hypotheses (weaker anomalies for pilot stocks; effect concentrated in short legs), each followed by results. Two auxiliary hypotheses (postpilot reversal; start/end dynamics) and robustness checks follow, then literature positioning and the contribution claim. The body runs from regulatory background and data to a balance check, the main DiD results, postpilot and dynamics results, and shorting activity. A dedicated robustness section covers sample periods, placebo tests, and NASDAQ stocks. Appendices give variable definitions, benchmark-adjusted returns, and a power analysis.",269  "writing_profile_keywords": [270   "natural experiment",271   "difference-in-differences",272   "hypothesis-driven",273   "Regulation SHO",274   "short-sale constraints",275   "anomalies",276   "mispricing vs risk",277   "placebo test"278  ],279  "confidence": 0.82,280  "notes": "Section I (regulatory background) was auto-tagged as literature; it is assigned 'other' here. Section IV was tagged as data but is the robustness section. Standard error type is not visible in the excerpts. Tables IX-XI (size split, uptick-rule restrictiveness split, value-weighted returns) suggest further subsample and alternative-specification analyses."281 },282 "deterministic_checks": {283  "roadmap_regex": false,284  "contribution_regex_in_intro": true,285  "magnitude_in_abstract": true,286  "abstract_n_sentences": 4,287  "intro_n_paragraphs": 10,288  "intro_n_words": 1364,289  "causal_words_in_abstract": 2,290  "hedge_words_in_abstract": 0,291  "stars_mentioned": false,292  "clustered_se_mentioned": false,293  "internet_appendix_mentioned": false,294  "section_roles_rule": {295   "0": "introduction",296   "1": "literature",297   "2": "data",298   "3": "other",299   "4": "data",300   "5": "conclusion",301   "6": "appendix",302   "7": "appendix",303   "8": "appendix",304   "9": "appendix"305  }306 },307 "schema_valid": true,308 "code_version": "87c73cd-dirty"309}
Files · b2ea7cd3a41b72854950b87ea6b3044f01e8a3c2
Menu

Theme